UMC (UMC)

$29.6B
Market Cap
22.4
P/E Ratio
1.01
Beta
4.14%
Dividend Yield
Piotroski 5/9Beneish M -2.91 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency appears modest, with a return on invested capital of 8.2% that fails to generate a clear spread over the cost of equity in this cyclical environment. The DuPont decomposition reveals an ROE of 11.0% driven primarily by robust net margins at 17.6%, while asset turnover remains constrained at 0.41x and leverage sits low at 1.52x, indicating earnings power relies on pricing strength rather than operational velocity or financial engineering. Quality metrics present a mixed signal; the Piotroski F-Score of 5/9 suggests moderate fundamental stability with some weakening trends, whereas the Beneish M-Score of -2.91 points to low manipulation risk and high confidence in reported earnings integrity despite sluggish revenue growth of just 2.3% year-over-year.

Valuation metrics suggest a premium pricing relative to historical norms given the current P/E multiple of 22.4x, which must be weighed against the modest top-line expansion trajectory. The DCF model implies an intrinsic fair value of $143, providing a specific anchor for potential re-rating if growth assumptions accelerate or margins expand further. This valuation gap requires careful calibration regarding implied future cash flows versus the current stagnation in revenue velocity; the market appears to be pricing in significant upside from the present 2.3% growth rate, assuming that margin resilience at 17.6% can sustain elevated multiples despite limited asset turnover efficiency.

No specific risk factor deltas, insider activity data, or Fama-French alpha figures were provided to refine this assessment beyond the fundamental and valuation synthesis. The divergence between a low manipulation score and a moderate Piotroski rating alongside flat revenue growth creates an environment where earnings quality is high but momentum remains subdued, leaving the investment case dependent on whether margin expansion can offset the lack of top-line acceleration in subsequent quarters.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$174$129$102
3%$203$143$110
4%$247$162$121

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $143 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
-2.91
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

29.0%
Gross Margin
17.6%
Net Margin
8.2%
ROIC
+2.3%
Revenue Growth (YoY)
-11.6%
Earnings Growth (YoY)
49.1B
Free Cash Flow
73%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

17.6%
Net Profit Margin
NI ÷ Revenue
×
0.41x
Asset Turnover
Revenue ÷ Assets
×
1.52x
Equity Multiplier
Assets ÷ Equity
=
11.0%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.52x
Debt / Equity
2.34x
Current Ratio
33.5x
Interest Coverage
-0.6x
Net Debt / EBITDA
110.4B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.11
Act: $0.10
-13.4%
Q3
✗ Miss
Est: $0.14
Act: $0.12
-11.4%
Q2
✓ Beat
Est: $0.12
Act: $0.19
+68.3%
Q1
✗ Miss
Est: $0.13
Act: $0.13
-1.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

15.6
Forward P/E
1.10
PEG Ratio
2.44
Price/Book
10M
Avg Volume
$12.68
52W High
$6.56
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$152M
Tracked Passive Exposure
3
ETFs Holding UMC
0.09%
Avg Weight in ETFs
$167B
Total ETF AUM

When investors buy or sell ETFs like SPEM or CWI, the fund manager is mechanically forced to buy or sell UMC shares regardless of UMC's individual fundamentals. We estimate $152M of passive capital is structurally linked to UMC through 3 tracked ETFs. Passive flows have a limited but growing influence on UMC's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 3 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in UMC to visualize passive redemption contagion across ETFs and collateral stocks.

UMC Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
UMCEpicenterVWOETFSPEMETFCWIETF2330UnknownTSMLow Risk700Unknown9988Unknown700Unknown
UMC Price Drop (%)0

If UMC (UMC) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Taiwan Semiconductor Manufacturing Co. Ltd. (2330) as the most exposed collateral stock, sharing 1 ETFs with UMC. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 3 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

UMC Ownership Dynamics

Ticker
UMC

Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

UMC Capital Efficiency

How efficiently does UMC convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$49.1B
EBITDA
$110.4B
FCF Conversion
44%
Reinvestment Rate
56%
44% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

UMC converts 44% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 56% reinvestment rate signals aggressive capacity expansion.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-142,216$15.92$35,278.72
2026-05-134,917$16.06$78,967.02
2026-05-11112$15.42$1,727.04
2026-05-081,504,222$15.16$22.8M
2026-05-0799,919$15.23$1.5M
2026-05-06100,300$14.01$1.4M
2026-05-041,322$13.05$17,252.1
2026-05-01253,473$13.06$3.3M
2026-04-24235$12.00$2,820
2026-04-23323$12.71$4,105.33
2026-04-223,162$12.33$38,987.46
2026-04-213,424$12.64$43,279.36
2026-04-20154,942$11.66$1.8M
2026-04-171,118,942$10.62$11.9M
2026-04-163,679$9.95$36,606.05
2026-04-15265,288$9.59$2.5M
2026-04-141,238$9.70$12,008.6
2026-04-13318,782$9.74$3.1M
2026-04-09758$9.47$7,178.26
2026-04-081,061$9.31$9,877.91
2026-04-07106,701$8.69$927,231.69
2026-04-0647,207$8.67$409,284.69
2026-04-0229,048$8.97$260,560.56
2026-03-30226$8.87$2,004.62
2026-03-2710,483$9.02$94,556.66
2026-03-2692,583$9.31$861,947.73
2026-03-2531$9.05$280.55
2026-03-2346,641$9.12$425,365.92
2026-03-20103$9.26$953.78
2026-03-19153,261$9.30$1.4M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare UMC to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.